| 翻訳と辞書 |
Wockhardt
Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with more than half of its revenue coming from Europe. In 2011–2012 its UK and USA sales alone were 475 million.〔(【引用サイトリンク】title=Who we are | Fact Sheet )〕 It has market presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.〔(【引用サイトリンク】title=Who we are | Overview )〕 The Company has a market capitalisation of over 〔(【引用サイトリンク】title=Wockhardt Ltd – Price, Fundamentals, Charts, Financials )〕 and an annual turnover of . It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 7,900 people globally.〔
〕 Wockhardt Hospitals is a subsidiary of the Wockhardt Group.
==History==
Wockhardt was founded by Habil Khorakiwala in the early 1960s.〔 His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973.〔 Wockhardt Ltd. was incorporated on July 8.1999.〔(【引用サイトリンク】title=Wockhardt Limited )〕 Wockhardt is often confused as a multinational because of its German sounding name.
Wockhardt is the first company outside of the US and Europe to manufacture recombinant human insulin.〔(【引用サイトリンク】title=Introducing Wockhardt )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Wockhardt」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|